|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operations | |||||
| Income (loss) from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Adjustments to reconcile net income (loss) to cash flows from operations: | |||||
| Depreciation and amortization | |||||
| Pension settlement charges | |||||
| Pension settlement and curtailment (gains) losses | |||||
| Net periodic pension and other postretirement costs | |||||
| Deferred income taxes | |||||
| Stock compensation | |||||
| Loss on product divestiture arrangement | |||||
| Reclassification of cumulative translation loss to earnings | |||||
| Loss on subsidiary liquidation | |||||
| Indefinite-lived asset impairments | |||||
| Other long-lived asset impairments | |||||
| Gain on early extinguishment of debt | |||||
| Other | |||||
| Changes in balance sheet items: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other | |||||
| Cash flows from (used in) operations – continuing operations | |||||
| Cash flows from (used in) operations – discontinued operations | |||||
| Cash flows from (used in) operations | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Acquisitions of developed technology and investments | |||||
| Proceeds from sale of marketable equity securities | |||||
| Other investing activities, net | |||||
| Cash flows from (used in) investing activities - continuing operations | |||||
| Cash flows from (used in) investing activities - discontinued operations | |||||
| Cash flows from (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Issuances of debt | |||||
| Increase in short term debt | |||||
| Repayments of debt | |||||
| Net (decreases) increases in debt with original maturities of three months or less | |||||
| Cash dividends on common stock | |||||
| Proceeds from stock issued under employee benefit plans | |||||
| Purchases of treasury stock | |||||
| Debt issuance costs | |||||
| Payments of contingent liabilities | |||||
| Other financing activities, net | |||||
| Cash flows from (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Less cash and cash equivalents of discontinued operations | |||||
| Cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
Loading...